• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过肽类和非肽类元素组合设计新一代合成C3a类似物及其生物活性

Design and biological activity of a new generation of synthetic C3a analogues by combination of peptidic and non-peptidic elements.

作者信息

Gerardy-Schahn R, Ambrosius D, Casaretto M, Grötzinger J, Saunders D, Wollmer A, Brandenburg D, Bitter-Suermann D

机构信息

Institut für Medizinische Mikrobiologie, Universität Mainz, F.R.G.

出版信息

Biochem J. 1988 Oct 1;255(1):209-16.

PMID:3264156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1135211/
Abstract

Based on published X-ray crystallographic data of the anaphylatoxic complement peptide C3a, we have synthesized a series of peptides with appropriate amino acid exchanges and a maximal length of 13 amino acids. N-terminal acylation of these optimized structures with epsilon-aminohexanoic acid and complex aromatic structures like fluorenylmethoxycarbonyl, 2-nitro-4-azidophenyl, fluoresceinyl and rhodaminyl leads to a dramatic increase in biological activity. The culmination of our synthetic efforts is a C3a analogue with 13 amino acid residues and a biological activity six times that of native C3a.

摘要

基于已发表的过敏毒素补体肽C3a的X射线晶体学数据,我们合成了一系列进行了适当氨基酸置换且最长为13个氨基酸的肽。用ε-氨基己酸以及芴甲氧羰基、2-硝基-4-叠氮基苯基、荧光素基和罗丹明基等复杂芳香结构对这些优化结构进行N端酰化,会使生物活性显著提高。我们合成工作的成果是一种具有13个氨基酸残基且生物活性为天然C3a六倍的C3a类似物。

相似文献

1
Design and biological activity of a new generation of synthetic C3a analogues by combination of peptidic and non-peptidic elements.通过肽类和非肽类元素组合设计新一代合成C3a类似物及其生物活性
Biochem J. 1988 Oct 1;255(1):209-16.
2
Reevaluation of the C3a active site using short synthetic C3a analogues.
Eur J Immunol. 1990 Jul;20(7):1463-8. doi: 10.1002/eji.1830200709.
3
Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.合成过敏毒素肽在广泛使用的生物学检测中的功能活性。
Clin Exp Immunol. 1992 May;88(2):368-72. doi: 10.1111/j.1365-2249.1992.tb03090.x.
4
Demonstration of a specific C3a receptor on guinea pig platelets.豚鼠血小板上特异性C3a受体的证实。
J Immunol. 1988 May 15;140(10):3496-501.
5
Induction of thromboxane release from macrophages by anaphylatoxic peptide C3a of complement and synthetic hexapeptide C3a 72-77.补体过敏毒素肽C3a和合成六肽C3a 72-77诱导巨噬细胞释放血栓素
J Immunol. 1983 Mar;130(3):1345-9.
6
C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.C3a诱导豚鼠血小板活化及刺激特异性可逆脱敏。
Agents Actions Suppl. 1982;11:147-57.
7
Suppression of humoral immune responses by synthetic C3a peptides.
J Immunol. 1983 Nov;131(5):2258-61.
8
Helical conformation at the carboxy-terminal portion of human C3a is required for full activity.
Biochemistry. 1986 Apr 22;25(8):1945-50. doi: 10.1021/bi00356a017.
9
Synthetic C3a analogs as specific inhibitors of C3a activity.
Immunopharmacology. 1981 Sep;3(3):275-80. doi: 10.1016/0162-3109(81)90009-6.
10
The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.豚鼠补体过敏毒素肽C3a。I. 纯化、理化性质及抗原特性。
Z Immunitatsforsch Immunobiol. 1978 Mar;154(2):135-46.

引用本文的文献

1
Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21.肽/受体协同进化解释了神经肽 TLQP-21 的脂肪分解功能。
Cell Rep. 2019 Sep 3;28(10):2567-2580.e6. doi: 10.1016/j.celrep.2019.07.101.
2
Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity.酰化刺激蛋白(ASP):细胞表面结合和三酰甘油合成活性的结构-功能决定因素
Biochem J. 1999 Aug 15;342 ( Pt 1)(Pt 1):41-8.
3
Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping.通过固定化抗原-抗体复合物的有限蛋白酶解和质谱肽图分析鉴定分子表位
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9848-52. doi: 10.1073/pnas.87.24.9848.
4
Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.合成过敏毒素肽在广泛使用的生物学检测中的功能活性。
Clin Exp Immunol. 1992 May;88(2):368-72. doi: 10.1111/j.1365-2249.1992.tb03090.x.
5
A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.一种具有双重C3a/C5a活性的重组杂合过敏毒素。
Biochem J. 1992 Nov 15;288 ( Pt 1)(Pt 1):261-6. doi: 10.1042/bj2880261.

本文引用的文献

1
PLATELET SEQUESTRATION IN MAN. I. METHODS.人体中的血小板隔离。一、方法。
J Clin Invest. 1964 May;43(5):843-55. doi: 10.1172/JCI104970.
2
Comparative study on biological effects of the guinea pig complement-peptide C3a and C3a-related synthetic oligopeptides.豚鼠补体肽C3a与C3a相关合成寡肽的生物学效应比较研究
Mol Immunol. 1980 Oct;17(10):1257-61. doi: 10.1016/0161-5890(80)90022-x.
3
Crystal structure analysis and molecular model of human C3a anaphylatoxin.人C3a过敏毒素的晶体结构分析与分子模型
Hoppe Seylers Z Physiol Chem. 1980 Sep;361(9):1389-99. doi: 10.1515/bchm2.1980.361.2.1389.
4
Purification and crystallization of human anaphylatoxin, C3a.
Hoppe Seylers Z Physiol Chem. 1980;361(6):977-80.
5
Preparation and properties of Nalpha-9-fluorenylmethyloxycarbonylamino acids bearing tert.-butyl side chain protection.带有叔丁基侧链保护基的Nα-9-芴甲氧羰基氨基酸的制备及其性质
Int J Pept Protein Res. 1980 Jan;15(1):59-66. doi: 10.1111/j.1399-3011.1980.tb02550.x.
6
Platelet-serotonin release by C3a and C5a: two independent pathways of activation.C3a和C5a诱导的血小板-血清素释放:两条独立的激活途径
J Immunol. 1981 Apr;126(4):1506-9.
7
C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.C3a诱导豚鼠血小板活化及刺激特异性可逆脱敏。
Agents Actions Suppl. 1982;11:147-57.
8
Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion.低区脱敏:细胞反应的一种刺激特异性控制机制。关于过敏毒素诱导血小板分泌的研究。
J Exp Med. 1982 Mar 1;155(3):698-710. doi: 10.1084/jem.155.3.698.
9
Synthetic C3a analogs as specific inhibitors of C3a activity.
Immunopharmacology. 1981 Sep;3(3):275-80. doi: 10.1016/0162-3109(81)90009-6.
10
The active site of C3a anaphylatoxin.C3a过敏毒素的活性位点。
J Biol Chem. 1980 Nov 25;255(22):10758-63.